Movers Roundup: Apple, Amylin Pharma

NEW YORK (AP)--Apple Inc. shares closed lower Monday after Chief Executive Steve Jobs unveiled a widely anticipated upgraded iPhone with a speedier Internet connection, GPS capabilities and lower price.

NEW YORK (AP)--Amylin Pharmaceuticals Inc. shares tumbled Monday on threats to the company's diabetes drug Byetta and its longer-lasting drug candidate Exenatide LAR.

LOS ANGELES (AP)--Shares of CytRx Corp. fell Monday after the biopharmaceutical company and said it will delay by one year a midstage study of its experimental drug to treat Lou Gehrig's Disease.